SHANGHAI – Juno Therapeutics inc., of Seattle, has decided to make its mark in China by partnering with Shanghai-based Wuxi Apptec, a contract research service platform, to build a new company from the ground up, dubbed JW Biotechnology (Shanghai) Ltd.